Gary Eldridge
17Patents
7h-index
13Co-inventors
59Inventor score
Filing activity: Mar 21, 2005 → Nov 19, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7612045B2 | Compounds, compositions and methods for controlling biofilms and bacterial infections | Chemistry; Metallurgy | 25 | Active |
| US7604978B2 | Inhibition of biofilm formation | Emerging Cross-Sectional Technologies | 17 | Expired |
| US8324264B1 | Inhibitors of bacterial biofilms and related methods | Chemistry; Metallurgy | 15 | Active |
| US9149522B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 10 | Active |
| US9017698B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 7 | Active |
| US9504743B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 7 | Active |
| US9149521B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 7 | Active |
| US9415097B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 7 | Active |
| US9415101B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 7 | Active |
| US10137192B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US9878037B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US9492522B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US11110169B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US10058608B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US7367933B2 | Screening of chemical compounds purified from biological sources | Physics | 0 | Active |
| US9562031B1 | Phenethyldihydrobenzodioxolones and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10525128B2 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.